China-based Northeast Pharmaceutical Co., Ltd (SHE: 000597) has entered into an investment framework agreement with Muscat Changming Investments LLC, leveraging business development plans and market demand in Oman and the Middle East.
Joint Venture Establishment and Objectives
The partnership aims to establish a joint venture (JV) in the Sultanate of Oman, focusing on the manufacturing of pharmaceutical preparations for sale in the Middle East and African markets. This strategic move is set to bolster the presence of Northeast Pharmaceutical in these regions, catering to the specific healthcare needs of the local populations.
Support and Promotion Plans
Muscat Changming will play a pivotal role in assisting Northeast Pharma in promoting their products within Oman and the broader Middle East region. This collaboration is expected to facilitate market penetration and enhance the brand visibility of Northeast Pharmaceutical’s offerings in the area.-Fineline Info & Tech
